NICE Guidelines (UK NHS)

The UK National Institute for Health and Care Excellence publishes systematic-review-based clinical guidelines for the NHS. Notably rigorous methodology, evidence-graded, and free. Useful cross-check when US guidance is silent or conflicting — though prescribing recommendations follow UK formulary.

Portals

• NICE Guidance — all types — guidelines, technology appraisals, quality standards.
• NICE Pathways — by condition/topic.
• BNF (British National Formulary) — UK drug formulary maintained alongside NICE.
• BNF for Children — pediatric formulary.

High-yield NICE guidelines for Med-Peds

• Hypertension in adults (NG136)
• Type 2 diabetes in adults (NG28)
• Asthma diagnosis & management (NG244) — joint NICE/BTS/SIGN 2024.
• COPD in over-16s (NG115)
• Chronic kidney disease (NG203)
• Pneumonia in adults (CG191)
• Feverish illness in children under 5 (NG143)
• Sepsis recognition and early management (NG51)
• Antimicrobial prescribing guidance index
• Depression in adults (NG222)
• Depression in children and young people (NG134)
• Postnatal care (NG194)

Why use NICE alongside US guidelines

• Independent systematic review — useful sanity check when US societies disagree (e.g., HTN thresholds, BPH treatment).
• More explicit cost-effectiveness reasoning (sometimes useful to surface in shared decision-making).
• Different formulary — do not transfer NICE drug doses directly; check DailyMed or AAP for US labeling.